Aim: The aim of this study was to investigate the influence of the IBD5 locus on clinical features of inflammatory bowel disease (IBD) patients, and its possible interaction with the CARD15 gene.
Patients And Methods: A cohort of 1,199 IBD patients (570 with CD and 629 with ulcerative colitis [UC]), and 357 healthy subjects were investigated. Information on clinical features was fully available for 855 IBD patients.
Aliment Pharmacol Ther
February 2006
Background: Two variants in the organic cation transporter gene cluster have been recently reported to confer susceptibility to Crohn's disease (CD).
Aim: To investigate these variants in CD and ulcerative colitis (UC), and their interaction with CARD15 gene and correlation to clinical subphenotypes.
Methods: Case-control association analysis was performed in 899 patients (444 CD and 455 UC) and 611 controls.
Background: Host genetic factors may be important in determining not only disease susceptibility, but also disease behaviour and response to therapy in inflammatory bowel disease. Two polymorphisms (C3435T and G2677T/A) of the multidrug resistance 1 gene have been correlated with the altered P-glycoprotein expression and function in humans, and associated with predisposition to ulcerative colitis and Crohn's disease.
Aim: To investigate the contribution of these polymorphisms to disease susceptibility and response to medical therapy.